Ovid Therapeutics (OVID) Earnings Date, Estimates & Call Transcripts $0.41 -0.02 (-5.39%) Closing price 04:00 PM EasternExtended Trading$0.41 +0.00 (+0.49%) As of 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Ovid Therapeutics Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 13Before Market OpensEstimatedActual EPS (Mar. 11) -$0.13 Beat By $0.03 Consensus EPS (Mar. 11) -$0.16 Ovid Therapeutics issued Q4 2024 earnings on March 11, 2025, reporting an EPS of -$0.13, which beat the consensus estimate of -$0.16 by $0.03. Quarterly revenue was reported to be $0.08 million, below the consensus estimate of $0.19 million. With a trailing EPS of -$0.38, Ovid Therapeutics' earnings are expected to decrease next year, from ($0.40) to ($0.64) per share. OVID Upcoming EarningsOvid Therapeutics' next earnings date is estimated for Tuesday, May 13, 2025, based off prior year's reporting schedules. Get Ovid Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ovid Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataOVID Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.OVID Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Ovid Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.13-$0.13-$0.13Q2 20253-$0.15-$0.11-$0.13Q3 20253-$0.16-$0.12-$0.14Q4 20253-$0.17-$0.12-$0.14FY 202512-$0.61-$0.48-$0.54Q1 20262-$0.18-$0.15-$0.17Q2 20262-$0.18-$0.14-$0.16Q3 20262-$0.18-$0.15-$0.17Q4 20262-$0.19-$0.16-$0.18FY 20268($0.73)($0.60)($0.67) Remove Ads Ovid Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/13/2025(Estimated)-------3/11/2025Q4 2024-$0.16-$0.13+$0.03-$0.13$0.19M$0.08M11/12/2024--$0.19-$0.20 -$0.01-$0.20$0.15M$0.17M8/13/2024Q2 2024-$0.22$0.12+$0.34$0.12$0.14M$0.17M5/14/2024Q1 2024-$0.23-$0.17+$0.06-$0.17$0.11M$0.15M3/8/2024Q4 2023-$0.17-$0.22 -$0.05-$0.22$0.10M$0.14M11/3/2023Q3 2023-$0.18-$0.16+$0.02-$0.16$0.09M$0.11M8/4/2023Q2 2023-$0.21-$0.18+$0.03-$0.18$0.09M$0.08M5/5/2023Q1 2023-$0.18-$0.19 -$0.01-$0.19$0.06M$0.07M Ovid Therapeutics Earnings - Frequently Asked Questions When is Ovid Therapeutics's earnings date? Ovid Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 13th, 2025 based off last year's report dates. Learn more on OVID's earnings history. Did Ovid Therapeutics beat their earnings estimates last quarter? In the previous quarter, Ovid Therapeutics (NASDAQ:OVID) reported ($0.13) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.16) by $0.03. Learn more on analysts' earnings estimate vs. OVID's actual earnings. How much revenue does Ovid Therapeutics generate each year? Ovid Therapeutics (NASDAQ:OVID) has a recorded annual revenue of $566,000.00. How much profit does Ovid Therapeutics generate each year? Ovid Therapeutics (NASDAQ:OVID) has a recorded net income of -$52.34 million. OVID has generated -$0.38 earnings per share over the last four quarters. What is Ovid Therapeutics's EPS forecast for next year? Ovid Therapeutics's earnings are expected to decrease from ($0.40) per share to ($0.64) per share in the next year. More Earnings Resources from MarketBeat Related Companies MCRB Earnings Results MGNX Earnings Results VIRI Earnings Results FTLF Earnings Results VXRT Earnings Results EDIT Earnings Results ELUT Earnings Results RENB Earnings Results ADVM Earnings Results COYA Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go HigherWhat Is the Price-to-Earnings (P/E) Ratio?Analysts Lift Archer Aviation Stock Despite Earnings Miss DigitalOcean Rides Cloud Wave and AI Hype to Strong EarningsPrice Targets on NVIDIA Rise in Front of Earnings Remove Ads This page (NASDAQ:OVID) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ovid Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ovid Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OVID Stock Free OVID Stock Alerts